Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Pricing of $4.1 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / December 7, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC),(OTC PINK: ENSCW), a clinical-stage biotech company applying transformative chemistry